Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs)

Ja Hye Myung, Sin jung Park, Andrew Z. Wang, Seungpyo Hong

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Circulating tumor cells (CTCs) have received a great deal of scientific and clinical attention as a biomarker for diagnosis and prognosis of many types of cancer. Given their potential significance in clinics, a variety of detection methods, utilizing the recent advances in nanotechnology and microfluidics, have been introduced in an effort of achieving clinically significant detection of CTCs. However, effective detection and isolation of CTCs still remain a tremendous challenge due to their extreme rarity and phenotypic heterogeneity. Among many approaches that are currently under development, this review paper focuses on a unique, promising approach that takes advantages of naturally occurring processes achievable through application of nanotechnology to realize significant improvement in sensitivity and specificity of CTC capture. We provide an overview of successful outcome of this biomimetic CTC capture system in detection of tumor cells from in vitro, in vivo, and clinical pilot studies. We also emphasize the clinical impact of CTCs as biomarkers in cancer diagnosis and predictive prognosis, which provides a cost-effective, minimally invasive method that potentially replaces or supplements existing methods such as imaging technologies and solid tissue biopsy. In addition, their potential prognostic values as treatment guidelines and that ultimately help to realize personalized therapy are discussed.

Original languageEnglish
Pages (from-to)36-47
Number of pages12
JournalAdvanced Drug Delivery Reviews
Volume125
DOIs
Publication statusPublished - 2018 Feb 1

Fingerprint

Circulating Neoplastic Cells
Nanotechnology
Biomimetics
Microfluidics
Tumor Biomarkers
Neoplasms
Biomarkers
Guidelines
Technology
Biopsy
Costs and Cost Analysis
Sensitivity and Specificity

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{00564cd086214b5989edc01260f5ef77,
title = "Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs)",
abstract = "Circulating tumor cells (CTCs) have received a great deal of scientific and clinical attention as a biomarker for diagnosis and prognosis of many types of cancer. Given their potential significance in clinics, a variety of detection methods, utilizing the recent advances in nanotechnology and microfluidics, have been introduced in an effort of achieving clinically significant detection of CTCs. However, effective detection and isolation of CTCs still remain a tremendous challenge due to their extreme rarity and phenotypic heterogeneity. Among many approaches that are currently under development, this review paper focuses on a unique, promising approach that takes advantages of naturally occurring processes achievable through application of nanotechnology to realize significant improvement in sensitivity and specificity of CTC capture. We provide an overview of successful outcome of this biomimetic CTC capture system in detection of tumor cells from in vitro, in vivo, and clinical pilot studies. We also emphasize the clinical impact of CTCs as biomarkers in cancer diagnosis and predictive prognosis, which provides a cost-effective, minimally invasive method that potentially replaces or supplements existing methods such as imaging technologies and solid tissue biopsy. In addition, their potential prognostic values as treatment guidelines and that ultimately help to realize personalized therapy are discussed.",
author = "Myung, {Ja Hye} and Park, {Sin jung} and Wang, {Andrew Z.} and Seungpyo Hong",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.addr.2017.12.005",
language = "English",
volume = "125",
pages = "36--47",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",

}

Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs). / Myung, Ja Hye; Park, Sin jung; Wang, Andrew Z.; Hong, Seungpyo.

In: Advanced Drug Delivery Reviews, Vol. 125, 01.02.2018, p. 36-47.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs)

AU - Myung, Ja Hye

AU - Park, Sin jung

AU - Wang, Andrew Z.

AU - Hong, Seungpyo

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Circulating tumor cells (CTCs) have received a great deal of scientific and clinical attention as a biomarker for diagnosis and prognosis of many types of cancer. Given their potential significance in clinics, a variety of detection methods, utilizing the recent advances in nanotechnology and microfluidics, have been introduced in an effort of achieving clinically significant detection of CTCs. However, effective detection and isolation of CTCs still remain a tremendous challenge due to their extreme rarity and phenotypic heterogeneity. Among many approaches that are currently under development, this review paper focuses on a unique, promising approach that takes advantages of naturally occurring processes achievable through application of nanotechnology to realize significant improvement in sensitivity and specificity of CTC capture. We provide an overview of successful outcome of this biomimetic CTC capture system in detection of tumor cells from in vitro, in vivo, and clinical pilot studies. We also emphasize the clinical impact of CTCs as biomarkers in cancer diagnosis and predictive prognosis, which provides a cost-effective, minimally invasive method that potentially replaces or supplements existing methods such as imaging technologies and solid tissue biopsy. In addition, their potential prognostic values as treatment guidelines and that ultimately help to realize personalized therapy are discussed.

AB - Circulating tumor cells (CTCs) have received a great deal of scientific and clinical attention as a biomarker for diagnosis and prognosis of many types of cancer. Given their potential significance in clinics, a variety of detection methods, utilizing the recent advances in nanotechnology and microfluidics, have been introduced in an effort of achieving clinically significant detection of CTCs. However, effective detection and isolation of CTCs still remain a tremendous challenge due to their extreme rarity and phenotypic heterogeneity. Among many approaches that are currently under development, this review paper focuses on a unique, promising approach that takes advantages of naturally occurring processes achievable through application of nanotechnology to realize significant improvement in sensitivity and specificity of CTC capture. We provide an overview of successful outcome of this biomimetic CTC capture system in detection of tumor cells from in vitro, in vivo, and clinical pilot studies. We also emphasize the clinical impact of CTCs as biomarkers in cancer diagnosis and predictive prognosis, which provides a cost-effective, minimally invasive method that potentially replaces or supplements existing methods such as imaging technologies and solid tissue biopsy. In addition, their potential prognostic values as treatment guidelines and that ultimately help to realize personalized therapy are discussed.

UR - http://www.scopus.com/inward/record.url?scp=85038361358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038361358&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2017.12.005

DO - 10.1016/j.addr.2017.12.005

M3 - Review article

C2 - 29247765

AN - SCOPUS:85038361358

VL - 125

SP - 36

EP - 47

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

ER -